Evaluation of predictors of erectile dysfunction and hypogonadism in men with types 2 diabetes mellitus

Abstract

Background: Now a day erectile dysfunction (ED) and hypogonadism of the patients with type 2 diabetes mellitus (T2DM) become two common complaints. The association among hypogonadism, erectile dysfunction and type 2 diabetes of man seem to be increased. The aim of this study was to evaluate the predictors of erectile dysfunction and hypogonadism in men with types 2 diabetes mellitus (T2DM). Methods: This was a cross-sectional study which was conducted in the Department of Shaheed Monsur Ali Medical College Hospital, Dhaka, Bangladesh Hospital, Bangladesh during the period from January 2019 to December 2019. In total 352 newly detected T2DM male patients, with complete data were finalized as the study population. All data were processed by using SPSS program version 23.0.Results: In this study, according to complement fixation test (cFT) and androgen deficiency in the aging male (ADAM) criteria, 119 (33.81%) participant had low cFT& ADAM positive under hypogonadal, 84 (23.86%) were with normal TT & ADAM negative (eugonadal), 37 (10.51%) were with low TT & ADAM negative (eugonadal), 112 (31.82%) were with normal TT & ADAM positive (eugonadal). On the other hand, according to the cFT and ADAM score in total 119 (33.81%) hypogonadal patients were with low cFT & ADAM positive. Besides this, 102 (43.78%) eugonadal patients were with normal cFT & ADAM negative and 131 (56.22%) eugonadal patients were with normal cFT & ADAM positive.Conclusions: Hence, universal screening of testosterone level and androgen deficiency symptoms is recommended in newly detected T2DM patients.